-
1 Comment
SonoScape Medical Corp is currently in a long term uptrend where the price is trading 21.1% above its 200 day moving average.
From a valuation standpoint, the stock is 10.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.6.
SonoScape Medical Corp's total revenue sank by 7.8% to $226M since the same quarter in the previous year.
Its net income has increased by 118.6% to $2M since the same quarter in the previous year.
Finally, its free cash flow grew by 185.1% to $35M since the same quarter in the previous year.
Based on the above factors, SonoScape Medical Corp gets an overall score of 4/5.
ISIN | CNE100002P91 |
---|---|
Exchange | SHE |
CurrencyCode | CNY |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 13B |
---|---|
PE Ratio | 93.91 |
Target Price | 40.1017 |
Dividend Yield | 1.0% |
Beta | -0.29 |
SonoScape Medical Corp. engages in the research and development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound diagnostic equipment, such as MRI, X-ray machine, and ultrasound; digestive and respiratory endoscopy products that includes gastroscopes, colonoscopes, bronchoscopes, etc.; minimally invasive surgical products, such as laparoscopes, thoracoscopes, hysteroscopes, arthroscopes, etc. for used in general surgery, thoracic surgery, urology and other departments; and cardiovascular interventional products. It is also involved in software industry; biotechnology development, technical consultation, and technology transfer; and medical endoscope soft endoscope treatment equipment business. Its products are used in radiology, OB/GYN, MSK, vascular, vein care, mobile service, urology, and vet products. SonoScape Medical Corp. was incorporated in 2002 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300633.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025